Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

361 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Patient self-reporting of tolerability using PRO-CTCAE in a randomized double-blind, placebo-controlled phase II trial comparing gemcitabine in combination with adavosertib or placebo in patients with platinum resistant or refractory epithelial ovarian carcinoma.
Madariaga A, Mitchell SA, Pittman T, Wang L, Bowering V, Kavak N, Quintos J, Chang K, Ramsahai J, Karakasis K, Welch SA, Dhani NC, Lheureux S, Oza AM. Madariaga A, et al. Among authors: mitchell sa. Gynecol Oncol. 2022 Nov;167(2):226-233. doi: 10.1016/j.ygyno.2022.08.006. Epub 2022 Aug 30. Gynecol Oncol. 2022. PMID: 36055813 Free PMC article. Clinical Trial.
Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
Dueck AC, Mendoza TR, Mitchell SA, Reeve BB, Castro KM, Rogak LJ, Atkinson TM, Bennett AV, Denicoff AM, O'Mara AM, Li Y, Clauser SB, Bryant DM, Bearden JD 3rd, Gillis TA, Harness JK, Siegel RD, Paul DB, Cleeland CS, Schrag D, Sloan JA, Abernethy AP, Bruner DW, Minasian LM, Basch E; National Cancer Institute PRO-CTCAE Study Group. Dueck AC, et al. Among authors: mitchell sa. JAMA Oncol. 2015 Nov;1(8):1051-9. doi: 10.1001/jamaoncol.2015.2639. JAMA Oncol. 2015. PMID: 26270597 Free PMC article.
Patient-Reported Outcomes in Cancer Clinical Trials: Measuring Symptomatic Adverse Events With the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
Kluetz PG, Chingos DT, Basch EM, Mitchell SA. Kluetz PG, et al. Among authors: mitchell sa. Am Soc Clin Oncol Educ Book. 2016;35:67-73. doi: 10.1200/EDBK_159514. Am Soc Clin Oncol Educ Book. 2016. PMID: 27249687 Free article. Review.
Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial.
Basch E, Pugh SL, Dueck AC, Mitchell SA, Berk L, Fogh S, Rogak LJ, Gatewood M, Reeve BB, Mendoza TR, O'Mara AM, Denicoff AM, Minasian LM, Bennett AV, Setser A, Schrag D, Roof K, Moore JK, Gergel T, Stephans K, Rimner A, DeNittis A, Bruner DW. Basch E, et al. Among authors: mitchell sa. Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):409-418. doi: 10.1016/j.ijrobp.2017.02.002. Epub 2017 Feb 10. Int J Radiat Oncol Biol Phys. 2017. PMID: 28463161 Free PMC article. Clinical Trial.
Routine surveillance for symptomatic toxicities with real-time clinician reporting in Danish breast cancer patients-Organization and design of the first national, cluster randomized trial using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE).
Pappot H, Baeksted C, Knoop A, Mitchell SA, Nissen A, Johansen C. Pappot H, et al. Among authors: mitchell sa. Breast J. 2019 Mar;25(2):269-272. doi: 10.1111/tbj.13204. Epub 2019 Feb 13. Breast J. 2019. PMID: 30761667
Content Validity of Anatomic Site-Specific Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Item Sets for Assessment of Acute Symptomatic Toxicities in Radiation Oncology.
Sandler KA, Mitchell SA, Basch E, Raldow AC, Steinberg ML, Sharif J, Cook RR, Kupelian PA, McCloskey SA. Sandler KA, et al. Among authors: mitchell sa. Int J Radiat Oncol Biol Phys. 2018 Sep 1;102(1):44-52. doi: 10.1016/j.ijrobp.2018.04.048. Epub 2018 Jun 5. Int J Radiat Oncol Biol Phys. 2018. PMID: 30102201
Danish Translation and Linguistic Validation of the U.S. National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
Bæksted C, Nissen A, Pappot H, Bidstrup PE, Mitchell SA, Basch E, Dalton SO, Johansen C. Bæksted C, et al. Among authors: mitchell sa. J Pain Symptom Manage. 2016 Aug;52(2):292-7. doi: 10.1016/j.jpainsymman.2016.02.008. Epub 2016 Apr 15. J Pain Symptom Manage. 2016. PMID: 27090851 Free article.
Feasibility and acceptability of electronic symptom surveillance with clinician feedback using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Danish prostate cancer patients.
Baeksted C, Pappot H, Nissen A, Hjollund NH, Mitchell SA, Basch E, Bidstrup PE, Dalton SO, Johansen C. Baeksted C, et al. Among authors: mitchell sa. J Patient Rep Outcomes. 2017;1(1):1. doi: 10.1186/s41687-017-0005-6. Epub 2017 Sep 12. J Patient Rep Outcomes. 2017. PMID: 29757324 Free PMC article.
Patient free text reporting of symptomatic adverse events in cancer clinical research using the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
Chung AE, Shoenbill K, Mitchell SA, Dueck AC, Schrag D, Bruner DW, Minasian LM, St Germain D, O'Mara AM, Baumgartner P, Rogak LJ, Abernethy AP, Griffin AC, Basch EM. Chung AE, et al. Among authors: mitchell sa. J Am Med Inform Assoc. 2019 Apr 1;26(4):276-285. doi: 10.1093/jamia/ocy169. J Am Med Inform Assoc. 2019. PMID: 30840079 Free PMC article.
361 results